For years, diagnosing cardiac amyloidosis has been regarded as an academic pursuit in …
Author
Dr Matthew Rees

Dr Matthew Rees
Dr. Matthew Rees, a Hematologist specializing in myeloma and amyloidosis, graduated from the University of Melbourne’s MD program at the top of his class in 2014. He trained at Peter MacCallum Cancer Centre, Austin Health, and Royal Melbourne Hospital and completed an advanced dysproteinemias fellowship at the Mayo Clinic. Dr. Rees’s research focuses on immunotherapy for plasma cell disorders and organ recovery strategies in light chain (AL) amyloidosis. He has presented internationally, including at the American Society of Clinical Oncology. He is a Myeloma Working Group member of the Australasian Leukaemia Lymphoma Group (ALLG) and disease lead for AL amyloidosis at St Vincent’s Hospital, Melbourne, Australia.